Frontlight ResearchEarly access
Taking people in NetherlandsPhase 1
Scan test for fibrosis in colorectal cancer that has spread to the abdomen
Tests a FAPI-PET scan to detect scarring in abdominal spread of colorectal cancer.
Key facts
- Who runs it
- Universitair Medisch Centrum Utrecht
- Where
- Amsterdam, NetherlandsSee the site
- Trial code
- Registry title
- The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET)
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 25 people, planned
- Started
- 12 Dec 2024
- Expected to end
- 31 May 2027
- Type of study
- Interventional
- Record updated
- 3 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with metastatic colorectal cancer. It studies FAPI-PET to detect tumor-associated fibrosis in colorectal peritoneal metastases.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Metastatic colorectal cancer
Where in Netherlands
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis StichtingAmsterdam, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Scan test for fibrosis in colorectal cancer that has spread to the abdomenGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 3 March 2026